Monday, February 21, 2005

Ximelagatran vs LMW Heparin and Warfarin for the Treatment of DVTs

"Oral ximelagatran administered in a fixed dose without coagulation monitoring, was as effective as enoxaparin/warfarin for treatment of deep vein thrombosis with or without pulmonary embolism and showed similar, low rates of bleeding. Increased levels of liver enzymes in 9.6% of ximelagatran-treated patients require regular monitoring; the mechanism requires further evaluation. Prospective assessment of coronary events in future studies is warranted." JAMA -- February 9, 2005, Fiessinger et al. 293 (6): 681